Non-Hodgkin Lymphoma News

New long-term analysis suggests follicular lymphoma can be cured - Fred Hutchinson Cancer Center

New long-term analysis suggests follicular lymphoma can be cured Fred Hutchinson Cancer Center

Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review - Frontiers

Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review Frontiers

Non-Hodgkin lymphoma survivor thankful for clinical trial - MD Anderson Cancer Center

Non-Hodgkin lymphoma survivor thankful for clinical trial MD Anderson Cancer Center

Bispecific Combo Doubles Overall Survival for Some Lymphomas, New Phase 3 Data Show - Oncology News Central

Bispecific Combo Doubles Overall Survival for Some Lymphomas, New Phase 3 Data Show Oncology News Central

Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN

Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN

T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma - Targeted Oncology

T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma Targeted Oncology

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree - Cureus

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree Cureus

New NHS Option for Relapsed Follicular Lymphoma - Medscape

New NHS Option for Relapsed Follicular Lymphoma Medscape

Bayer proposes $7.2 billion settlement to resolve Roundup weedkiller cases - CBS News

Bayer proposes $7.2 billion settlement to resolve Roundup weedkiller cases CBS News

Non-Hodgkin lymphoma and HIV - Aidsmap

Non-Hodgkin lymphoma and HIV Aidsmap

Dave Coulier Reveals New Cancer Diagnosis Months After Beating Non-Hodgkin Lymphoma - People.com

Dave Coulier Reveals New Cancer Diagnosis Months After Beating Non-Hodgkin Lymphoma People.com

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial - Nature

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial Nature

Groundbreaking treatment fighting back against Non-Hodgkin’s Lymphoma - KPLC 7 News

Groundbreaking treatment fighting back against Non-Hodgkin’s Lymphoma KPLC 7 News

Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank - Wiley Online Library

Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library

Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 - The ASCO Post

Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 The ASCO Post

Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature - Frontiers

Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers

Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma - Targeted Oncology

Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma Targeted Oncology

Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription - Nature

Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription Nature

Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about MD Anderson coming to Austin - MD Anderson Cancer Center

Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about MD Anderson coming to Austin MD Anderson Cancer Center

Primary Extranodal Marginal Zone Non-Hodgkin Lymphoma of the Prostate: A Case Report - Frontiers

Primary Extranodal Marginal Zone Non-Hodgkin Lymphoma of the Prostate: A Case Report Frontiers

Researchers Identify Predictors of Response to CAR T-Cell Therapy in B-Cell Non-Hodgkin’s Lymphoma - Cleveland Clinic

Researchers Identify Predictors of Response to CAR T-Cell Therapy in B-Cell Non-Hodgkin’s Lymphoma Cleveland Clinic

Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report - Frontiers

Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report Frontiers

Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma - Nature

Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma Nature

Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case - Cureus

Non-Hodgkin's Lymphoma in Pregnancy: A Report of a Rare Case Cureus

A Milky Mystery: Chylothorax Unmasking Non-Hodgkin Lymphoma - Cureus

A Milky Mystery: Chylothorax Unmasking Non-Hodgkin Lymphoma Cureus

Non-Hodgkin lymphoma survival rate: Outlook and more - Medical News Today

Non-Hodgkin lymphoma survival rate: Outlook and more Medical News Today

Non-Hodgkin Lymphoma (NHL): Jon and Julie's Story - BMT InfoNet

Non-Hodgkin Lymphoma (NHL): Jon and Julie's Story BMT InfoNet

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma - Cureus

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma Cureus

Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin’s lymphoma - Nature

Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin’s lymphoma Nature